Loading events...
This event listing is based on historical patterns and may not be officially confirmed. Dates, venue, and details are subject to change. Please verify with the event organizer or official website before making travel arrangements.
Verify on official websiteAccelerating the Discovery of Molecular Glues Against Novel Undruggable Targets. Enabling Rapid Target Selection, Discovery & Rational Design of Degrading & Non-Degrading Molecular Glue to Develop Potent, Selective & Safer Cures for Cancer & Beyond. Molecular glues are leading the charge in the race to drug the previously undruggable, and 2025 has seen continued investment and partnerships driving innovation in this field. Returning as the industry’s only dedicated meeting, the 4th Molecular Glue Drug Development Summit brings top experts from biopharma and academia together for intimate networking and scientific content sharing. Designed to address the unique challenges of molecular glues, this meeting will provide actionable strategies to accelerate the development of safer, more selective candidates toward the clinic. Attendees will explore cutting-edge topics including target selection principles, rational design frameworks, sensitive assay technologies, lead optimization, and AI/ML approaches for rapid and reliable glue discovery. Delve into emerging frontiers in non-degrading molecular glues and approaches outside oncology t o unlock new therapeutic modalities, expand glues to novel indications, and stay ahead of the curve in the glues space. If you’re looking to lead the way in the molecular glue space , connect with the brightest minds, and gain practical insights to drive programs forward – this is your chance to solve the field’s unique challenges and shape the next wave of innovative therapies.
Accelerating the Discovery of Molecular Glues Against Novel Undruggable Targets. The event covers key topics including Molecular Glues, Targeted Protein Degradation, Drug Discovery, and 4 more specialized areas, bringing together thought leaders, practitioners, and innovators for knowledge exchange and collaboration. Designed for professionals in the Pharmaceuticals, Biotechnology, Drug Development sectors, the conference features keynote presentations, panel discussions, and interactive sessions addressing the most pressing challenges and opportunities in the industry. Attendees benefit from networking opportunities with industry peers, exposure to cutting-edge developments, and actionable insights that can be applied to drive organizational growth and innovation. Taking place in Boston, USA, the event serves as a strategic gathering point for professionals seeking to stay at the forefront of their field. With presentations from domain experts and opportunities for hands-on learning, 4th Molecular Glue Drug Development Summit 2026 provides a comprehensive platform for professional development, business networking, and discovering the latest solutions transforming the industry landscape. The event program is designed to deliver maximum value through a combination of keynote presentations from thought leaders, interactive panel discussions exploring pressing industry challenges, and dedicated networking sessions that facilitate meaningful professional connections. Whether you are a seasoned industry veteran or an emerging professional, the conference offers tailored content tracks that address varying experience levels and areas of specialization, ensuring every attendee walks away with relevant and implementable insights.
TBA at TBA
Accelerating the Discovery of Molecular Glues Against Novel Undruggable Targets. Enabling Rapid Target Selection, Discovery & Rational Design of Degrading & Non-Degrading Molecular Glue to Develop Potent, Selective & Safer Cures for Cancer & Beyond. Molecular glues are leading the charge in the race to drug the previously undruggable, and 2025 has seen continued investment and partnerships driving innovation in this field. Returning as the industry’s only dedicated meeting, the 4th Molecular Glue Drug Development Summit brings top experts from biopharma and academia together for intimate networking and scientific content sharing. Designed to address the unique challenges of molecular glues, this meeting will provide actionable strategies to accelerate the development of safer, more selective candidates toward the clinic. Attendees will explore cutting-edge topics including target selection principles, rational design frameworks, sensitive assay technologies, lead optimization, and AI/ML approaches for rapid and reliable glue discovery. Delve into emerging frontiers in non-degrading molecular glues and approaches outside oncology t o unlock new therapeutic modalities, expand glues to novel indications, and stay ahead of the curve in the glues space. If you’re looking to lead the way in the molecular glue space , connect with the brightest minds, and gain practical insights to drive programs forward – this is your chance to solve the field’s unique challenges and shape the next wave of innovative therapies.
This event aligns with current industry trends:
4th Molecular Glue Drug Development Summit 2026 takes place on Tuesday, January 27, 2026 to Thursday, January 29, 2026 in Boston. All times are in UTC.
4th Molecular Glue Drug Development Summit 2026 features 1 speaker, including TBA (TBA, TBA).
4th Molecular Glue Drug Development Summit 2026 focuses on Molecular Glues, Targeted Protein Degradation, Drug Discovery, Oncology, Undruggable Targets and 5 more themes. Related topics include Molecular Glues, Targeted Protein Degradation, Drug Discovery, Oncology.
4th Molecular Glue Drug Development Summit 2026 addresses key industry trends including AI-accelerated drug discovery and target identification, Cell and gene therapy commercialization scaling, Real-world evidence and decentralized clinical trials, Precision medicine and companion diagnostics, mRNA platform expansion beyond vaccines. Attendees can expect sessions, panels, and networking focused on these emerging areas.
4th Molecular Glue Drug Development Summit 2026 is designed for C-suite executives and senior leaders, Department managers and team leads, Industry practitioners and specialists, Startup founders and entrepreneurs, Consultants and advisory professionals. Key reasons to attend include: Gain cutting-edge insights in Molecular Glues, Targeted Protein Degradation, Drug Discovery from industry-leading speakers and practitioners; Network with industry professionals and decision-makers gathering in Boston for focused knowledge exchange; Stay ahead of the latest trends and innovations reshaping the Pharmaceuticals, Biotechnology landscape.
4th Molecular Glue Drug Development Summit 2026 takes place at Hilton Boston Logan Airport in Boston, USA.
WebMobi provides event registration, ticketing, mobile apps, check-in, and analytics — all with zero platform fees.
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox
Receive curated event recommendations based on your interests.
See how WebMobi helps you manage registration, check-in, and analytics.
Request a DemoOr start free trial →4th Molecular Glue Drug Development Summit 2026 scores highest for learning value (9/10). Networking score: 8/10, Learning score: 9/10, Business deals score: 7/10. The event typically attracts 250+ attendees.